| Primary |
| Urinary Tract Infection |
65.1% |
| Cystitis |
6.3% |
| Atrial Fibrillation |
3.2% |
| Blood Pressure |
1.6% |
| Cardiac Disorder |
1.6% |
| Cystoscopy |
1.6% |
| Dementia |
1.6% |
| Heart Rate Irregular |
1.6% |
| Hyperlipidaemia |
1.6% |
| Infection |
1.6% |
| Infection Prophylaxis |
1.6% |
| Multiple Sclerosis |
1.6% |
| Product Used For Unknown Indication |
1.6% |
| Prophylaxis Urinary Tract Infection |
1.6% |
| Prostatitis |
1.6% |
| Recurrent Uti |
1.6% |
| Sinusitis |
1.6% |
| Sleep Disorder |
1.6% |
| Urinary Tract Infection Staphylococcal |
1.6% |
|
| Hepatic Cirrhosis |
7.5% |
| Optic Nerve Injury |
7.5% |
| Pneumonia |
7.5% |
| Pulmonary Fibrosis |
7.5% |
| Urinary Tract Infection |
7.5% |
| Vomiting |
7.5% |
| Weight Decreased |
7.5% |
| Autoimmune Hepatitis |
5.0% |
| Interstitial Lung Disease |
5.0% |
| Liver Injury |
5.0% |
| Nausea |
5.0% |
| Weight Increased |
5.0% |
| White Blood Cell Count Decreased |
5.0% |
| Anaphylactic Reaction |
2.5% |
| Anaphylactic Shock |
2.5% |
| Decreased Appetite |
2.5% |
| Documented Hypersensitivity To Administered Drug |
2.5% |
| Drug Hypersensitivity |
2.5% |
| Haemorrhage Urinary Tract |
2.5% |
| Heart Rate Increased |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
36.7% |
| Foetal Exposure During Pregnancy |
14.6% |
| Urinary Tract Infection |
11.7% |
| Pain |
7.1% |
| Cystitis |
3.2% |
| Drug Use For Unknown Indication |
3.2% |
| Hypertension |
3.2% |
| Migraine |
2.5% |
| Eclampsia |
2.1% |
| Fibromyalgia |
2.1% |
| Goitre |
2.1% |
| Arthritis |
1.8% |
| Atrial Fibrillation |
1.4% |
| Pyelonephritis |
1.4% |
| Stent Placement |
1.4% |
| Hypertonic Bladder |
1.1% |
| Insomnia |
1.1% |
| Irritable Bowel Syndrome |
1.1% |
| Multiple Sclerosis |
1.1% |
| Osteoporosis |
1.1% |
|
| Drug Hypersensitivity |
38.0% |
| Weight Decreased |
9.9% |
| Hypoaesthesia |
8.5% |
| Maternal Exposure During Pregnancy |
7.0% |
| Anxiety |
4.2% |
| Nocturia |
4.2% |
| White Blood Cells Urine Positive |
4.2% |
| Allergy To Chemicals |
2.8% |
| Pneumonia |
2.8% |
| Renal Failure |
2.8% |
| White Blood Cell Count Decreased |
2.8% |
| Alanine Aminotransferase Increased |
1.4% |
| Anaemia |
1.4% |
| Arthralgia |
1.4% |
| Asthenia |
1.4% |
| Asthma |
1.4% |
| Bradycardia |
1.4% |
| Dyspnoea |
1.4% |
| Fatigue |
1.4% |
| Foetal Growth Restriction |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.3% |
| Drug Use For Unknown Indication |
11.6% |
| Hypertension |
6.4% |
| Multiple Sclerosis |
5.9% |
| Pain |
5.4% |
| Depression |
5.1% |
| Osteoporosis |
4.5% |
| Urinary Tract Infection |
4.4% |
| Rheumatoid Arthritis |
4.2% |
| Hiv Infection |
4.1% |
| Anxiety |
3.0% |
| Diabetes Mellitus |
2.7% |
| Crohn's Disease |
2.0% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Blood Cholesterol Increased |
1.9% |
| Prophylaxis |
1.9% |
| Abdominal Pain Upper |
1.8% |
| Asthma |
1.7% |
| Cerebrovascular Accident |
1.6% |
| Relapsing-remitting Multiple Sclerosis |
1.6% |
|
| Urinary Tract Infection |
19.1% |
| Vomiting |
13.0% |
| Weight Increased |
6.9% |
| Pneumonia |
4.9% |
| Staphylococcal Infection |
4.9% |
| Vision Blurred |
4.9% |
| Weight Decreased |
4.9% |
| Ventricular Septal Defect |
4.1% |
| Syncope |
3.7% |
| Urticaria |
3.7% |
| Ventricular Dysfunction |
3.7% |
| Pain In Extremity |
3.3% |
| White Blood Cell Count Increased |
3.3% |
| Wrist Fracture |
3.3% |
| Drug Ineffective |
2.8% |
| Nephrolithiasis |
2.8% |
| Pyrexia |
2.8% |
| Transient Ischaemic Attack |
2.8% |
| White Blood Cell Count Decreased |
2.8% |
| Pulmonary Embolism |
2.4% |
|
| Interacting |
| Chronic Myeloid Leukaemia |
50.0% |
| Urinary Tract Infection |
50.0% |
|
| Urinary Tract Infection |
100.0% |
|
